CYTOSORBENTS CORP's ticker is CTSO and the CUSIP is 23283X206. A total of 82 filers reported holding CYTOSORBENTS CORP in Q3 2018. The put-call ratio across all filers is 0.75 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $394,000 | 0.0% | 49,500 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $394,000 | +4825.0% | 49,500 | +2052.2% | 0.00% | – |
| Q4 2019 | $8,000 | -63.6% | 2,300 | -50.0% | 0.00% | – |
| Q3 2019 | $22,000 | +46.7% | 4,600 | +100.0% | 0.00% | – |
| Q2 2019 | $15,000 | -75.8% | 2,300 | -72.3% | 0.00% | – |
| Q1 2019 | $62,000 | -7.5% | 8,300 | 0.0% | 0.00% | – |
| Q4 2018 | $67,000 | -37.4% | 8,300 | 0.0% | 0.00% | – |
| Q3 2018 | $107,000 | +13.8% | 8,300 | 0.0% | 0.00% | – |
| Q2 2018 | $94,000 | – | 8,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CM Management, LLC | 450,000 | $1,616 | 1.58% |
| Skylands Capital, LLC | 2,793,470 | $10,028,557 | 1.44% |
| Sargent Investment Group, LLC | 1,289,546 | $4,629,470 | 1.12% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 237,940 | $854,205 | 0.96% |
| Avenir Corp | 2,719,732 | $9,763,838 | 0.86% |
| Granahan Investment Management | 1,616,587 | $5,803,547 | 0.18% |
| Seelaus Asset Management LLC | 20,450 | $73 | 0.06% |
| Cowen Prime Advisors LLC | 42,301 | $151,861 | 0.05% |
| HighMark Wealth Management LLC | 10,000 | $35,900 | 0.03% |
| Key Client Fiduciary Advisors, LLC | 12,000 | $43,080 | 0.02% |